Investment Strategy
Lilly Endowment is one of the largest private foundations in the United States, with total assets of approximately $46 billion as of mid-2024. Founded in 1937 by J.K. Lilly Sr. and his sons, J.K. Lilly Jr. and Eli Lilly, the endowment is headquartered in Indianapolis and focuses its grantmaking on religion, education, and community development, with a particular emphasis on Indiana-based initiatives. Annual grantmaking has typically ranged from $500 million to over $1 billion in recent years.
The endowment’s investment portfolio is defined by its heavy concentration in Eli Lilly and Company stock. This single-stock concentration is unusual among large foundations and reflects the endowment’s origins as a family philanthropic vehicle funded with shares of the pharmaceutical company. The dramatic appreciation of Eli Lilly shares in recent years, driven by the company’s success in diabetes and obesity treatments, has pushed the endowment’s total assets to historic highs.
Beyond its Eli Lilly holdings, the endowment maintains diversified positions in public equities, fixed income, and a small allocation to alternative investments. The overall investment approach is conservative relative to peer foundations, reflecting the reality that the endowment’s returns are largely driven by the performance of a single stock rather than by active portfolio management decisions.
Private Markets Approach
The Lilly Endowment’s private markets activity is modest compared to foundations of similar size. The endowment’s investment model does not require the complex alternatives portfolios that characterize institutions like the Ford Foundation or MacArthur Foundation, because the core Eli Lilly stock position has delivered exceptional returns over multiple decades.
The endowment does maintain some diversified investment holdings, and its 990-PF filings show positions in various investment vehicles beyond the core stock holding. However, the scale of these allocations is small relative to the total asset base, and the endowment does not appear to maintain the type of large-scale private equity or venture capital commitment programs that other top-20 foundations operate.
For fund managers, the Lilly Endowment represents an unusual institutional profile. The endowment’s concentrated portfolio means that traditional alternatives pitches focused on diversification benefits may not resonate in the same way they would with a more conventionally structured foundation. Managers who do engage with the endowment should understand its Indiana-centric philanthropic mission and the unique dynamics of a portfolio dominated by a single public equity position.
The endowment’s annual grantmaking is funded primarily through stock sales and dividends from the Eli Lilly position, a model that has worked well during periods of strong stock performance but introduces concentration risk that the endowment’s leadership has acknowledged over the years.
Frequently Asked Questions
What is the Lilly Endowment's investment portfolio composed of?
The Lilly Endowment's portfolio is uniquely concentrated in Eli Lilly and Company (NYSE: LLY) stock, which has historically represented the vast majority of the endowment's assets. This concentration is a legacy of the endowment's founding by J.K. Lilly Sr. and his sons in 1937 using shares of the pharmaceutical company. While the endowment has diversified somewhat over the decades, Eli Lilly stock remains the dominant holding. The endowment's asset value has grown substantially in recent years, driven largely by the strong performance of Eli Lilly shares.
Does the Lilly Endowment invest in private equity or alternative assets?
The Lilly Endowment maintains a modest allocation to diversified investments beyond its core Eli Lilly stock holdings. The endowment's IRS Form 990-PF filings indicate holdings in diversified equities, fixed income, and some alternative investments. However, the alternatives allocation is small relative to the total portfolio, and the endowment's investment approach has historically been conservative. Fund managers should understand that the Lilly Endowment's investment profile is fundamentally different from most large foundations due to its stock concentration.
How does the Lilly Endowment select external investment managers?
The Lilly Endowment operates with a lean staff from its Indianapolis headquarters and maintains a relatively low public profile compared to other foundations of its size. The endowment's investment management approach reflects its concentrated portfolio structure, with limited need for the large external manager rosters typical of diversified institutional investors. Fund managers interested in the Lilly Endowment should review its publicly available 990-PF filings for insight into current holdings and recognize that opportunities for new manager relationships may be limited given the portfolio's structure.
